n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Neurilemmoma

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium has been researched along with Neurilemmoma* in 2 studies

Other Studies

2 other study(ies) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Neurilemmoma

ArticleYear
Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET.
    Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2

    We report the case of a 75-year-old man with history of prostate cancer whose left intracavernous lesion was successfully characterized by 3 PETs performed successively with different tracers. This poorly characterized tumor was initially discovered on an MRI conducted to investigate an acute diplopia and slowly growing during follow-up. On 18F-FDG PET, the lesion showed no significant uptake, and no extracranial lesion was found nor did it have increased 68Ga-DOTATOC uptake. Finally, this tumor displayed a high 18F-choline uptake, and no extracranial lesion was revealed with this tracer. The diagnosis of schwannoma without malignancy criterion was proven by biopsy.

    Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Neurilemmoma; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography

2022
Incidental double neurinoma detected by 18F-choline PET/CT scan in a prostate cancer patient.
    Nuclear medicine review. Central & Eastern Europe, 2020, Volume: 23, Issue:1

    Topics: Aged; Choline; Humans; Incidental Findings; Male; Neurilemmoma; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms

2020